Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL194260 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL26343 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL57881 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL18109766 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL1901678 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL609551 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL60307 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL2231460 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL59116 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 | |
| Methacrylic Acid SCHEMBL3082635 | 1.00 | TDP1 (0.36) | TDP1TGFBR1TET2ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1929 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | Anthro Energy, Inc. (US) | 2026-03-26 | — | — | US | claimed |
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | SHOFU INC. (JP) | 2026-02-17 | — | — | US | claimed |
| EP-4665832-A1 | WELL PLATE FOR IMAGING | The University of British Columbia (CA) | 2025-12-24 | — | — | EP | claimed |
| WO-2025215191-A1 | CURABLE COMPOSITIONS COMPRISING AN ACIDIFIED ANHYDRIDE OLIGOMER USEFUL IN DEINKING PROCESSES | ARKEMA FRANCE (FR) | 2025-10-16 | — | — | WO | claimed |
| WO-2025215194-A1 | ENHANCED REMOVABILITY OF NAIL COATINGS USING ACIDIC COPOLYMERS FOR TRIGGERED REMOVAL WITH AQUEOUS BASED REMOVER | ARKEMA FRANCE (FR) | 2025-10-16 | — | — | WO | claimed |
| WO-2025215193-A1 | ACIDIC OLIGOMERS USED IN DEINKING PROCESS | ARKEMA FRANCE (FR) | 2025-10-16 | — | — | WO | claimed |
| US-20250187262-A1 | Photocurable Materials for the Production of Dental Prostheses and Devices | PAC-DENT, INC. (US) | 2025-06-12 | — | — | US | claimed |
| EP-3681962-B1 | ACRYLIC EMULSIONS MODIFIED WITH FUNCTIONAL (METH)ACRYLATES TO ENABLE CROSSLINKING | Miwon North America Incorporated (US) | 2025-05-21 | — | — | EP | claimed |
| EP-3577176-B1 | LOW TEMPERATURE CURABLE ADHESIVE COMPOSITIONS | SIMPSON STRONG TIE CO INC (US) | 2024-10-23 | — | — | EP | claimed |
| CN-118591770-A | UV curable quantum dot formulations | 昭荣化学工业株式会社 | 2024-09-03 | — | — | CN | claimed |
| EP-0847050-A2 | Optical recording medium | Mitsubishi Chemical Corporation (JP) | 1998-06-10 | — | — | EP | claimed |
| US-4678846-A | HIGH AND LOW MOLECULAR WEIGHT | TH. GOLDSCHMIDT AG (DE) | 1987-07-07 | — | — | US | claimed |
| US-4526920-A | Contains poly(meth)acrylic ester of oxy or polyoxyalkane polyol, polymerization initiator, filler | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-07-02 | — | — | US | claimed |
| EP-0077849-B1 | RESIN-FORMING MATERIAL AND RESTORATIVE MATERIAL SUITABLE FOR MEDICAL OR DENTAL USE | KANEBO, LTD. (JP) | 1985-02-20 | — | — | EP | claimed |
| EP-0077849-A1 | Resin-forming material and restorative material suitable for medical or dental use | KANEBO, LTD. (JP) | 1983-05-04 | — | — | EP | claimed |
| US-4371566-A | CURABEL, PENTAERYTHRITOL ACRYLATES AND METHACRYLATES | PANELGRAPHIC CORPORATION (US) | 1983-02-01 | — | — | US | claimed |
| EP-0060272-A1 | ABRASION RESISTANT COATING COMPOSITION | PANELGRAPHIC CORPORATION (US) | 1982-09-22 | — | — | EP | claimed |
| WO-1982000782-A1 | ABRASION RESISTANT COATING COMPOSITION | PANELGRAPHIC CORP (US) | 1982-03-18 | — | — | WO | claimed |
| US-4308119-A | Abrasion-resistant optical coating composition containing pentaerythritol based polyacrylates and cellulose esters | PANELGRAPHIC CORPORATION (US) | 1981-12-29 | — | — | US | claimed |
| WO-1980001805-A1 | RADIATION CURABLE CELLULOSIC POLYACRYLIC ABRASION RESISTANT COATING | PANELGRAPHIC CORP (US) | 1980-09-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260088310-A1 | SHAPED BATTERY CELL AND METHOD OF MANUFACTURE | FTO, DCX, TET1 | TDP1 234/4885TGFBR1 2859/4885TET2 19/4885 |
| US-12552956-B2 | Photopolymerizable type dental surface coating composition | CDH1, DCLRE1A, ITGA1 | TDP1 1482/4885TGFBR1 349/4885TET2 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.